TuHURA Biosciences, Inc. (HURA)

TuHURA Biosciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022
Cash & Equivalents	6.3	3.62	12.66	3.67	1.54	11.78
Cash & Short-Term Investments	6.3	3.62	12.66	3.67	1.54	11.78
Cash Growth	1.26%	-71.40%	245.35%	138.76%	-86.97%	11.80%
Other Receivables	-	0.5	-	-	-	-
Total Trade Receivables	-	0.5	-	-	-	-
Other Current Assets	0.68	0.5	6.95	0.49	1.74	1.48
Total Current Assets	6.98	4.62	19.61	4.16	3.27	13.26
Net Property, Plant & Equipment	0.68	0.69	0.32	0.2	0.71	0.09
Other Intangible Assets	11.28	11.28	-	-	-	-
Goodwill	10.74	10.74	-	-	-	-
Other Long-Term Assets	0.03	0.03	0.03	-	-	2.6
Total Assets	29.7	27.35	19.97	4.36	3.98	15.95

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022
Accounts Payable	5.86	5.52	5.17	3.44	3.08	3.99
Short-Term Debt	-	0.2	-	-	-	-
Current Portion of Leases	0.21	0.2	0.16	0.02	-	-
Other Current Liabilities	-	-	-	0.14	-	-
Total Current Liabilities	6.07	5.92	5.33	3.6	3.08	3.99
Long-Term Debt	-	-	-	2.32	-	-
Other Long-Term Liabilities	0.2	0.2	-	-	0.17	0.16
Total Long-Term Liabilities	0.2	0.2	-	2.32	0.17	0.16
Total Liabilities	6.51	6.42	5.37	5.92	3.25	4.15

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022
Preferred Stock	-	-	-	0.02	10.65	12.55
Common Stock	-	0.06	0.04	0.01	0	0
Additional Paid-in Capital	171.57	161.78	125.4	86.89	141.44	135.58
Accumulated Other Comprehensive Income	-	-	-	-	0.02	0.02
Retained Earnings	-148.72	-141.18	-111.12	-88.47	-151.38	-136.36
Total Common Shareholders' Equity	22.85	20.65	14.32	-1.56	0.73	11.8
Shareholders' Equity	23.19	20.93	14.59	-1.56	0.73	11.8
Total Liabilities & Equity	29.7	27.35	19.97	4.36	3.98	15.95

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2023	FY 2022
Period Ending	Mar 31, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Jun 30, 2023	Jun 30, 2022
Total Debt	0.21	0.4	0.16	2.34	0	0
Net Cash (Debt)	6.09	3.22	12.5	1.32	1.54	11.78
Net Cash Growth	0.60%	-74.21%	846.73%	-14.00%	-86.97%	11.80%
Net Cash Per Share	0.14	0.07	0.67	1.75	33.16	338.64
Book Value	22.85	20.65	14.32	-1.56	0.73	11.8
Book Value Per Share	0.54	0.43	0.77	-2.07	15.79	339.08
Tangible Book Value	0.83	-1.36	14.32	-1.56	0.73	11.8
Tangible Book Value Per Share	0.02	-0.03	0.77	-2.07	15.79	339.08

SEC Filings: 10-K · 10-Q

Data Source: Fiscal.ai Last updated: May 15, 2026

Financial data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 27, 2026

Data Sources Report a data error